Neurocognitive changes in cancer patients.
OBJECTIVE
To review the neurocognitive changes in patients with cancer. This will include and overview of signs and symptoms, diagnostic tests, nursing interventions, and supportive pharmacologic measures for the treatment of acute and chronic changes in cognition.


METHODS
Published articles and reference books.


CONCLUSIONS
The treatment modalities used for individuals with cancer can produce cognitive deficits that may negatively affect quality of life. The clinician's consistent assessment and evaluation of contributing factors such as co-morbidities, medications, age, and metabolic abnormalities assists in identifying the etiology for cognitive changes and guiding appropriate interventions.


CONCLUSIONS
Understanding the need for assessment of changes in cognition and the direct and indirect factors that contribute to these changes is critical for the oncology nurse caring for patients with cancer to provide an appropriate plan of care.
Baumgartner
Karen
K
M. D. Anderson Cancer Center, Houston, TX, USA. kbaumgar@mdanderson.org
D000208:Acute Disease; D016543:Central Nervous System Neoplasms / Q000150:complications* / Q000628:therapy; D002908:Chronic Disease; D003072:Cognition Disorders / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D003937:Diagnosis, Differential; D006801:Humans; D009422:Nervous System Diseases / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D024802:Nurse's Role; D009730:Nursing Assessment; D009859:Oncology Nursing; D010347:Patient Care Planning; D012307:Risk Factors